|
1. Oncology’s ‘last-mile problem’: NCI care bypasses patients who need it most Full story
2. US cancer mortality falls as incidence climbs — for some: 10 things to know Full story
3. Drug shortages, biosimilar pressure, reimbursement erosion and financial toxicity on patients — the pressures squeezing oncology service lines are the agenda Nov. 4-5 in Chicago at Becker’s Fall Oncology Executive Summit. Apply to attend as a reviewer here.
4. HHS launches Operation TrailBlazer to reclaim clinical trial edge: 5 notes Full story
5. RWJBarnabas Health, Rutgers open $225M cancer center Full story
6. Top 25 US healthcare research organizations, per Nature Full story
7. FDA immunotherapy approvals fell in 2025: 5 things to know Full story
8. St. Jude maintains sole pediatric cancer designation from WHO Full story
9. Karmanos Cancer Institute sees 47% growth in 5 years Full story
10. 3 cancer drugs in shortage Full story
Becker’s Learning Opportunities
11. Infusion overtime cut 50%, provider satisfaction up 25%: Calmer days for oncology teams here.
12. Cancer is on the forefront of their minds: How leaders are meeting patients’ screening demands here.
13. EMS reimbursement pressure is rising. See what leaders should fix before revenue stalls here.
14. Interested in more? See Becker’s full lineup of webinars and whitepapers.
|
